Mifepristone (RU 486)
Recent articles in the press have suggested that mifepristone (RU 486 - Roussel Uclaf) can effectively and safely induce an abortion. The drug is currently available only in France and China, but the manufacturer has also applied for a license in the United Kingdom. Mifepristone has been used on an investigational basis in the USA as an abortifacient and for treatment of Cushing's disease and breast cancer, but no manufacturer has applied to the US Food and Drug Administration for approval to market the drug in this country....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Mifepristone (RU 486)
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 833
Article Code: 833b
Date: December 14, 1990
Volume: 32
Pages: 112-114
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 833
Article Code: 833b
Date: December 14, 1990
Volume: 32
Pages: 112-114
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)